SCHEMBL4765992

SCHEMBL4765992

CCN1CCN(c2nc(-c3ccccc3CN3CCOCC3)cc3ccccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 2/20 0.44
TSHR P16473 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43
METAP2 P50579 1/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4766948 0.99 PIK3CD (0.50) PIK3CDSMN1; SMN2CYP1A2TSHRCYP3A4
SCHEMBL4769934 0.88 KMT2A (0.43) PIK3CDSMN1; SMN2CYP1A2CYP2D6KMT2A
Hydrochloric Acid SCHEMBL4766871 0.87 KMT2A (0.44) PIK3CDSMN1; SMN2CYP1A2TSHRCYP2D6
SCHEMBL4765995 0.83 ACP1 (0.48) PIK3CDSMN1; SMN2KMT2AMEN1ALDH1A1
Hydrochloric Acid SCHEMBL4766949 0.82 ACP1 (0.47) PIK3CDKMT2AMEN1ALDH1A1LMNA
SCHEMBL4769787 0.80 PIK3CD (0.48) PIK3CDSMN1; SMN2CYP1A2KMT2AMEN1
SCHEMBL7778369 0.80 KMT2A (0.43) PIK3CDSMN1; SMN2CYP1A2TSHRCYP2D6
SCHEMBL4766228 0.80 KMT2A (0.49) PIK3CDSMN1; SMN2CYP1A2TSHRCYP2D6
SCHEMBL4773119 0.80 AHR (0.54) PIK3CDSMN1; SMN2CYP1A2KMT2AMEN1
Hydrochloric Acid SCHEMBL4768974 0.79 PIK3CD (0.47) PIK3CDKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US disclosed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US disclosed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US disclosed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013460-A1 Condensed pyridine compound MUSK, HTR1A, PAX3 PIK3CD 3238/4885SMN1; SMN2 27/4885CYP1A2 2126/4885
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives MUSK, HTR1A, RYR1 PIK3CD 3004/4885SMN1; SMN2 37/4885CYP1A2 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.